These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21211644)

  • 21. The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes.
    Immonen A; Kinnunen T; Sirven P; Taivainen A; Houitte D; Peräsaari J; Närvänen A; Saarelainen S; Rytkönen-Nissinen M; Maillere B; Virtanen T
    Clin Exp Allergy; 2007 Jun; 37(6):939-47. PubMed ID: 17517108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.
    Rudulier CD; Tonti E; James E; Kwok WW; Larché M
    Allergy; 2019 Nov; 74(11):2157-2166. PubMed ID: 31077596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
    Alexander C; Ying S; B Kay A; Larché M
    Clin Exp Allergy; 2005 Jan; 35(1):52-8. PubMed ID: 15649266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 25. In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children.
    Pascal M; Konstantinou GN; Masilamani M; Lieberman J; Sampson HA
    Clin Exp Allergy; 2013 Jan; 43(1):116-27. PubMed ID: 23278886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.
    Pène J; Desroches A; Paradis L; Lebel B; Farce M; Nicodemus CF; Yssel H; Bousquet J
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):571-8. PubMed ID: 9802364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.
    Tarzi M; Klunker S; Texier C; Verhoef A; Stapel SO; Akdis CA; Maillere B; Kay AB; Larché M
    Clin Exp Allergy; 2006 Apr; 36(4):465-74. PubMed ID: 16630151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design of hypoallergens applied to the major cat allergen Fel d 1.
    Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M
    Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.
    Counsell CM; Bond JF; Ohman JL; Greenstein JL; Garman RD
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):884-94. PubMed ID: 8939151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract.
    Nanda A; O'connor M; Anand M; Dreskin SC; Zhang L; Hines B; Lane D; Wheat W; Routes JM; Sawyer R; Rosenwasser LJ; Nelson HS
    J Allergy Clin Immunol; 2004 Dec; 114(6):1339-44. PubMed ID: 15577832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.
    Renand A; Archila LD; McGinty J; Wambre E; Robinson D; Hales BJ; Thomas WR; Kwok WW
    J Allergy Clin Immunol; 2015 Dec; 136(6):1627-1635.e13. PubMed ID: 26371841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.
    Hulse KE; Reefer AJ; Engelhard VH; Satinover SM; Patrie JT; Chapman MD; Woodfolk JA
    J Allergy Clin Immunol; 2008 Mar; 121(3):756-762.e4. PubMed ID: 18086491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of T cell epitopes in alphas1-casein in cow's milk allergic, atopic and non-atopic children.
    Ruiter B; Trégoat V; M'rabet L; Garssen J; Bruijnzeel-Koomen CA; Knol EF; Hoffen E
    Clin Exp Allergy; 2006 Mar; 36(3):303-10. PubMed ID: 16499640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Treatments for Allergy: Advances in Peptide Immunotherapy.
    Calzada D; Baos S; Cremades L; Cardaba B
    Curr Med Chem; 2018; 25(19):2215-2232. PubMed ID: 29205109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy.
    Grundström J; Neimert-Andersson T; Kemi C; Nilsson OB; Saarne T; Andersson M; van Hage M; Gafvelin G
    Int Arch Allergy Immunol; 2012; 157(2):136-46. PubMed ID: 21985799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity.
    Verhoef A; Alexander C; Kay AB; Larché M
    PLoS Med; 2005 Mar; 2(3):e78. PubMed ID: 15783262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgE and IgG binding patterns and T-cell recognition of Fel d 1 and non-Fel d 1 cat allergens.
    Hales BJ; Chai LY; Hazell L; Elliot CE; Stone S; O'Neil SE; Smith WA; Thomas WR
    J Allergy Clin Immunol Pract; 2013; 1(6):656-65.e1-5. PubMed ID: 24565714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy.
    Moldaver DM; Bharhani MS; Rudulier CD; Wattie J; Inman MD; Larché M
    J Allergy Clin Immunol; 2019 Mar; 143(3):1087-1099.e4. PubMed ID: 29906527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.